ACTIM 2.5MG TAB

 4

This medication contains Bisoprolol Fumarate, a cardioselective β1-adrenergic blocker used to treat hypertension, heart failure, atrial fibrillation, and angina pectoris. Its long half-life allows for once-daily dosing. Bisoprolol is well tolerated due to its β1 selectivity and is an effective alternative to non-selective β-blockers like Carvedilol and Labetalol. It can be used alone or with other drugs to manage high blood pressure and is suitable for patients with COPD.

10 in stock

SKU: 14739 Category:

Description

Bisoprolol Fumarate: A Cardioselective β1-Adrenergic Blocker for Hypertension and More
Introduction
Bisoprolol fumarate, a highly cardioselective β1-adrenergic blocker (s-BB), plays a crucial role in managing various cardiovascular conditions. Let’s explore its uses, benefits, and safety profile.
Mechanism of Action
Cardioselectivity: Bisoprolol selectively blocks β1 receptors in the heart.
These receptors normally bind to hormones called catecholamines (e.g., adrenaline).
By inhibiting β1 receptors, bisoprolol reduces heart rate and contractility, helping manage cardiovascular conditions.
Clinical Uses
Hypertension (High Blood Pressure):
Bisoprolol effectively lowers blood pressure.
It is a preferred choice due to its potency and tolerability1.
Heart Failure (HFrEF):
Bisoprolol improves symptoms, reduces hospitalizations, and prolongs survival in heart failure patients.
It is part of the standard treatment regimen for heart failure with reduced ejection fraction (HFrEF).
Atrial Fibrillation:
Bisoprolol helps control heart rate in patients with atrial fibrillation (AF).
It is recommended for AF patients with HFrEF2.
Angina Pectoris:
Bisoprolol reduces angina episodes by decreasing myocardial oxygen demand.
It is a valuable option for managing stable angina.
Advantages
Long Half-Life:
Bisoprolol’s extended half-life allows for once-daily dosing, improving patient compliance.
β1 Selectivity:
Unlike non-selective β-blockers (e.g., carvedilol, labetalol), bisoprolol predominantly targets β1 receptors.
This selectivity minimizes adverse effects on bronchial function and peripheral circulation.
Considerations
COPD Patients:Bisoprolol is suitable for patients with chronic obstructive pulmonary disease (COPD) due to its β1 selectivity3.
It does not exacerbate bronchospasm.
Conclusion
Bisoprolol fumarate, with its cardioselectivity and favorable safety profile, remains a cornerstone in cardiovascular therapy. Consult your healthcare provider to explore its benefits for your specific condition.